Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to attend LIVE "Market on Close" program each Friday with John Rowland. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Astrazeneca Plc ADR (AZN)

Astrazeneca Plc ADR (AZN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 239,936,928
  • Shares Outstanding, K 3,101,162
  • Annual Sales, $ 54,073 M
  • Annual Income, $ 7,035 M
  • EBIT $ 10,003 M
  • EBITDA $ 16,691 M
  • 60-Month Beta 0.41
  • Price/Sales 4.45
  • Price/Cash Flow 12.33
  • Price/Book 5.89

Options Overview Details

View History
  • Implied Volatility 22.65% ( +1.07%)
  • Historical Volatility 19.57%
  • IV Percentile 49%
  • IV Rank 36.23%
  • IV High 34.77% on 10/31/24
  • IV Low 15.77% on 05/28/24
  • Put/Call Vol Ratio 0.17
  • Today's Volume 2,812
  • Volume Avg (30-Day) 14,701
  • Put/Call OI Ratio 0.35
  • Today's Open Interest 183,918
  • Open Int (30-Day) 182,874

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 15 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/25
See More
  • Average Estimate 1.10
  • Number of Estimates 5
  • High Estimate 1.14
  • Low Estimate 1.07
  • Prior Year 1.03
  • Growth Rate Est. (year over year) +6.80%

Price Performance

See More
Period Period Low Period High Performance
1-Month
73.54 +4.64%
on 02/21/25
78.36 -1.79%
on 03/05/25
+2.15 (+2.87%)
since 02/18/25
3-Month
63.75 +20.70%
on 12/20/24
78.36 -1.79%
on 03/05/25
+12.31 (+19.04%)
since 12/18/24
52-Week
62.75 +22.63%
on 11/18/24
87.68 -12.23%
on 08/30/24
+11.10 (+16.86%)
since 03/18/24

Most Recent Stories

More News
Lilly's Jaypirca Gets CHMP Nod for 2nd Leukemia Indication in Europe

Eli Lilly and Company LLY announced that the European Medicines Agency's Committee for Medicinal Products for Human Use (“CHMP”) has given a positive opinion recommending approval of its BTK inhibitor,...

AZN : 76.96 (-0.53%)
JNJ : 163.60 (+0.47%)
LLY : 819.18 (-0.68%)
ABBV : 212.60 (-0.87%)
Pharma Stock Roundup: LLY Ups U.S. Manufacturing Investments & More

This week, Eli Lilly LLY announced that it is increasing its manufacturing capacity in the United States by building four new plants. AstraZeneca’s AZN phase III study on breast cancer candidate, camizestrant,...

AZN : 76.96 (-0.53%)
MRK : 94.31 (-0.51%)
LLY : 819.18 (-0.68%)
3 Magnificent Growth Stocks to Buy Right Now

In a sense, every investor is a growth investor. Even those who are primarily seeking income enjoy when the stocks they buy increase in value. But which stocks are likely to deliver growth over the next...

AZN : 76.96 (-0.53%)
VRTX : 514.06 (+0.06%)
LLY : 819.18 (-0.68%)
What's a Good Price for AstraZeneca Stock?

Healthcare companies are interesting because they are not highly correlated with macroeconomic factors.

AZN : 76.96 (-0.53%)
2 Healthcare Stocks That Tumbled in 2024...but Could See an Impressive Comeback in 2025

Vertex Pharmaceuticals (NASDAQ: VRTX) and AstraZeneca (NASDAQ: AZN), two of the world's leading drugmakers, missed last year's strong market rally. Both finished 2024 slightly in the red. They're already...

AZN : 76.96 (-0.53%)
VRTX : 514.06 (+0.06%)
Pharma Stock Roundup: PFE, LLY, NVO, LLY and AZN's Q4 Earnings Update

This week was loaded with earnings releases of many large drugmakers. Novo Nordisk NVO, Merck MRK, Pfizer PFE, Eli Lilly LLY, AstraZeneca AZN and AbbVie announced their fourth-quarter and full-year 2024...

AZN : 76.96 (-0.53%)
NVO : 80.79 (+0.80%)
MRK : 94.31 (-0.51%)
LLY : 819.18 (-0.68%)
PFE : 26.20 (+0.58%)
Why AstraZeneca Topped the Market on Thursday

A fresh earnings release was the news development powering AstraZeneca 's (NASDAQ: AZN) share price higher on Thursday. Investors were clearly impressed by the pharmaceutical company's numbers, as the...

AZN : 76.96 (-0.53%)
AstraZeneca Plc (AZN) Q4 2024 Earnings Call Transcript

AZN earnings call for the period ending December 31, 2024.

AZN : 76.96 (-0.53%)
AZN Q4 Earnings Lag, Sales Beat, Stock Up on China Probe Update

AstraZeneca’s AZN fourth-quarter 2024 core earnings of $1.05 per American depositary share (“ADS”) missed the Zacks Consensus Estimate of $1.07. Core earnings of $2.09 per share rose 44% year over...

AZN : 76.96 (-0.53%)
MRK : 94.31 (-0.51%)
AMGN : 316.07 (-0.35%)
SNY : 59.03 (+0.19%)
An Analyst Just Tripled His Price Target on This Quantum Computing Stock

An analyst just tripled his price target on IonQ as quantum computing momentum surges.

GOOGL : 159.83 (-2.71%)
ANSS : 322.91 (-0.63%)
AZN : 76.96 (-0.53%)
$SPX : 5,607.52 (-1.19%)
IONQ : 24.12 (-3.25%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 56% Buy with a Weakening short term outlook on maintaining the current direction.

See More Share

Business Summary

AstraZeneca plc, is one of the largest biopharmaceutical companies in the world. AstraZeneca's business can be broken down into separate lines based on therapeutic classes. These include cardiovascular, respiratory, immunology, oncology, rare diseases and other.In July 2021 AstraZeneca closed the acquisition...

See More

Key Turning Points

3rd Resistance Point 78.41
2nd Resistance Point 78.08
1st Resistance Point 77.73
Last Price 76.96
1st Support Level 77.05
2nd Support Level 76.72
3rd Support Level 76.37

See More

52-Week High 87.68
Fibonacci 61.8% 78.15
Last Price 76.96
Fibonacci 50% 75.21
Fibonacci 38.2% 72.27
52-Week Low 62.75

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar